| Name | Title | Contact Details |
|---|
MMI Preparatory School Mission Statement: To provide dedicated area students with a comprehensive and inspiring 6th-12th grade college preparatory program that maximizes each individuals academic, social, and character potential in preparation for success in college and beyond.
The official site of Central Valley Fuego FC. Your hub for club news, announcements, schedule, and more!
Reily Foods Company is a 5th-generation, family-owned business established in 1902 by William B. Reily. Originally focused on coffee roasting and distribution in New Orleans, the company has grown into a prominent manufacturer and marketer of various specialty food and beverage products. Its Luzianne brand is particularly well-known for coffee and tea, including the popular Luzianne Iced Tea. The company offers a diverse range of products, including condiments, dressings, baking products, and seasonings. Reily Foods also operates a coffee service division that delivers coffee to homes and businesses. With a commitment to quality, Reily Foods supplies its products to grocery stores and restaurants across the United States and select international markets.
Apellis Pharmaceuticals is a global biopharmaceutical company based in Waltham, Massachusetts. The company is focused on developing innovative therapies that target the complement system, a crucial part of the immune system. Apellis aims to create life-changing treatments for various debilitating diseases through its commitment to scientific research and patient care. The company has a diverse pipeline of products, including EMPAVELI, which is approved for treating paroxysmal nocturnal hemoglobinuria and is being investigated for other conditions. SYFOVRE is in development for geographic atrophy, along with a combination therapy involving APL-APL-3007. Apellis is also exploring RNA therapies and gene-edited treatments for multiple therapeutic areas. With a global presence in countries such as the US, Canada, and several European nations, Apellis serves patients and healthcare providers affected by diseases related to the complement system. The company reported approximately $709 million in U.S. net product revenues for the full year 2024, reflecting its strong market position and commitment to advancing its therapeutic offerings.
It was 50 years ago—on January 12, 1965—that Clark Abt started on his journey in a small Cambridge office to create a place where innovation, bold thinking and creativity could tackle the toughest social issues of the day. Almost 50 years later, Abt Associates has grown into a global company of more than 2,700 employees with offices around the world. Although the company has changed and grown far beyond its early days, one thing remains constant: Abt`s mission to improve the quality of life and economic well-being of people worldwide.